Evaluating Chemotherapy at the End of Life--Reply

Affiliations

¹ Center for Research on End-of-Life Care, Weill Cornell Medical College, New York, New York2Division of Geriatrics and Palliative Medicine, Department of Medicine, Weill Cornell Medical College, New York, New York.
² Herbert Irving Comprehensive Cancer Center, Department of Medicine, College of Physicians and Surgeon, New York, New York4Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York.
³ Center for Research on End-of-Life Care, Weill Cornell Medical College, New York, New York5Department of Radiology, Weill Cornell Medical College, New York, New York.

Comment

Holly G Prigerson et al. JAMA Oncol. 2016 Jan.

. 2016 Jan;2(1):144.

doi: 10.1001/jamaoncol.2015.4111.

¹ Center for Research on End-of-Life Care, Weill Cornell Medical College, New York, New York2Division of Geriatrics and Palliative Medicine, Department of Medicine, Weill Cornell Medical College, New York, New York.
² Herbert Irving Comprehensive Cancer Center, Department of Medicine, College of Physicians and Surgeon, New York, New York4Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York.
³ Center for Research on End-of-Life Care, Weill Cornell Medical College, New York, New York5Department of Radiology, Weill Cornell Medical College, New York, New York.

No abstract available

Comment on

Chemotherapy Use, Performance Status, and Quality of Life at the End of Life.
Prigerson HG, Bao Y, Shah MA, Paulk ME, LeBlanc TW, Schneider BJ, Garrido MM, Reid MC, Berlin DA, Adelson KB, Neugut AI, Maciejewski PK. Prigerson HG, et al. JAMA Oncol. 2015 Sep;1(6):778-84. doi: 10.1001/jamaoncol.2015.2378. JAMA Oncol. 2015. PMID: 26203912 Free PMC article.
Evaluating Chemotherapy at the End of Life.
Frickhofen N, Maier BO. Frickhofen N, et al. JAMA Oncol. 2016 Jan;2(1):142. doi: 10.1001/jamaoncol.2015.4102. JAMA Oncol. 2016. PMID: 26767554 No abstract available.
Evaluating Chemotherapy at the End of Life.
Provenzano AF, Carvajal RD. Provenzano AF, et al. JAMA Oncol. 2016 Jan;2(1):142-3. doi: 10.1001/jamaoncol.2015.4105. JAMA Oncol. 2016. PMID: 26767555 No abstract available.
Evaluating Chemotherapy at the End of Life.
Buiting HM, van den Heuvel MM. Buiting HM, et al. JAMA Oncol. 2016 Jan;2(1):143-4. doi: 10.1001/jamaoncol.2015.4108. JAMA Oncol. 2016. PMID: 26767556 No abstract available.